Your Medical Device - From Idea to Market - Your end-to-end Partner

News

2025-06-04

Camilla Oldgren Appointed New CEO of GBA Key2Compliance AB

GBA Key2Compliance AB is pleased to announce the appointment of Camilla Oldgren as its new Chief Executive Officer (CEO), effective June 1, 2025. Camilla brings over 30 years of experience in the life sciences industry, with deep expertise in pharmaceuticals, medical devices, and consulting services. Her professional journey spans executive leadership in established companies as well as advisory roles helping businesses navigate growth and transformation.

show all News

Know what's inside

Your Medical Device - From Idea to Market - Your end-to-end Partner

Expert Guidance and Testing for MedTech Success

At GBA Group, we are committed to advancing the MedTech industry through comprehensive solutions, expert guidance, and precise testing. We combine consulting and laboratory testing in a unique way to offer self-contained packages from a single source, supported by our in-house experts throughout the entire lifecycle of medical devices. Our specialized divisions work in unison to offer unparalleled support to medical device manufacturers.

Our Commitment

We deliver seamless, integrated solutions. Our expert guidance and testing ensure your success in the MedTech industry, from initial development to market approval and beyond.

Service

Contact

Ready to take your medical devices to the next level? Contact us today to learn how our comprehensive MedTech solutions can support your needs.

Email: medical-devices@gba-group.com

News

4.6.2025

Camilla Oldgren Appointed New CEO of GBA Key2Compliance AB

GBA Key2Compliance AB is pleased to announce the appointment of Camilla Oldgren as its new Chief Executive Officer (CEO), effective June 1, 2025.

Camilla brings over 30 years of experience in the life sciences industry, with deep expertise in pharmaceuticals, medical devices, and consulting services. Her professional journey spans executive leadership in established companies as well as advisory roles helping businesses navigate growth and transformation.

29.1.2025

HPLC analyses for the characterization of non-volatile organic compounds (NVOC)

HPLC Chemical Characterization – Compliant and Precise GBA Medical Device Services, a part of GBA Group, is excited to announce the expansion of its service portfolio to include high-performance liquid chromatography (HPLC) analyses for the characterization of non-volatile organic compounds (NVOC).